Different Clinical Characteristics Among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae Monomicrobial Bacteremia

다국어 초록 (Multilingual Abstract)

This study aimed to compare the clinical presentations of Aeromonas hydrophila, A. veronii biovar sobria and A. caviae monomicrobial bacteremia by a retrospective method at three hospitals in Taiwan during an 8-yr period. There were 87 patients with A. hydrophila bacteremia, 45 with A. veronii biovar sobria bacteremia and 22 with A. caviae bacteremia.
Compared with A. hydrophila and A. veronii biovar sobria bacteremia, A. caviae bacteremia was more healthcare-associated (45 vs 30 and 16%; P = 0.031). The patients with A. caviae bacteremias were less likely to have liver cirrhosis (27 vs 62 and 64%;P = 0.007) and severe complications such as shock (9 vs 40 and 47%; P = 0.009) and thrombocytopenia (45 vs 67 and 87%; P = 0.002). The APACHE II score was the most important risk factor of Aeromonas bacteremia-associated mortalities. The APACHE II scores of A. caviae bacteremias were lower than A. hydrophila bacteremia and A. veronii biovar sobria bacteremia (7 vs 14 and 16 points; P = 0.002). In conclusion, the clinical presentation of A. caviae bacteremia was much different from A. hydrophila and A. veronii biovar sobria bacteremia. The severity and mortality of A. caviae bacteremia were lower than A. hydrophila or A. veronii biovar sobria bacteremia.

참고문헌 (Reference)

1 Lamy B, "colBVH Study Group, Kodjo A. Accuracy of 6 commercial systems for identifying clinical Aeromonas isolates" 67 : 9-14, 2010

2 Yucel N, "Virulence properties and characterization of aeromonads isolated from foods of animal origin and environmental sources" 73 : 855-860, 2010

3 Such J, "Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis" 14 : 371-376, 2002

4 Laohachai KN, "The role of bacterial and non-bacterial toxins in the induction of changes in membrane transport: implications for diarrhea" 42 : 687-707, 2003

5 Abbott SL, "The genus Aeromonas: biochemical characteristics, atypical reactions, and phenotypic identification schemes" 41 : 2348-2357, 2003

6 Hazen TC, "Prevalence and distribution of Aeromonas hydrophila in the United States" 36 : 731-738, 1978

7 Clinical and Laboratory Standards Institute, "Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Document M45-A" Wayne, PA: Clinical and Laboratory Standards Institute 2006

8 Ormen O, "Lack of agreement between biochemical and genetic identification of Aeromonas spp" 113 : 203-207, 2005

9 Chiva M, "Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats" 15 : 145-150, 2003

10 Burgos A, "In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents" 9 : 413-417, 1990

11 Motyl MR, "In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents" 28 : 151-153, 1985

12 Quigley EM, "Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited" 41 : 557-561, 1996

13 Krzymińska S, "Enteropathogenic activity and invasion of HEp-2 cells by Aeromonas caviae clinical isolates" 52 : 277-283, 2003

14 Sherlock CH, "Does Aeromonas hydrophila preferentially colonize the bowels of patients with hematologic malignancies" 7 : 63-68, 1987

15 Lay CJ, "Different clinical characteristics between polymicrobial and monomicrobial Aeromonas bacteremia: study of 216 cases" 49 : 2415-2421, 2010

16 Wu CJ, "Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan" 54 : 151-158, 2007

17 Ko WC, "Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia" 40 : 267-273, 2000

18 Lye DJ, "Characterization of Aeromonas virulence using an immunocompromised mouse model" 54 : 195-198, 2007

19 Janda JM, "Biochemical and exoenzymatic properties of Aeromonas species" 3 : 223-232, 1985

20 Garcia-Tsao G, "Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites" 108 : 1835-1841, 1995

21 Lee LN, "Bacteremia due to Aeromonas hydrophila: a report of 40 episodes" 85 : 123-132, 1986

22 Harris RL, "Bacteremia caused by Aeromonas species in hospitalized cancer patients" 7 : 314-320, 1985

23 강재명, "Aeromonas 균혈증의 임상적 특징과 예후와 관련된 위험요인" 대한감염학회 37 (37): 161-166, 2005

24 Janda JM, "Aeromonas species in septicemia: laboratory characteristics and clinical observations" 19 : 77-83, 1994

25 Dryden M, "Aeromonas septicemia: relationship of species and clinical features" 21 : 111-114, 1989

26 Duthie R, "Aeromonas septicaemia in Hong Kong species distribution and associated disease" 30 : 241-244, 1995

27 Galindo CL, "Aeromonas hydrophila cytotoxic enterotoxin activates mitogen-activated protein kinases and induces apoptosis in murine macrophages and human intestinal epithelial cells" 279 : 37597-37612, 2004

28 Ko WC, "Aeromonas bacteremia: review of 59 episodes" 20 : 1298-1304, 1995

29 Funada H, "Aeromonas bacteremia in patients with hematologic diseases" 36 : 171-174, 1997